Sorrento Therapeutics Inc (NASDAQ:SRNE)

13.26
Delayed Data
As of Feb 26
 +0.08 / +0.61%
Today’s Change
3.10
Today|||52-Week Range
16.40
+31.68%
Year-to-Date
No recent news for Sorrento Therapeutics Inc.

Today’s Trading

Previous close13.18
Today’s open13.00
Day’s range-- - --
Volume150,914
Average volume (3 months)437,095
Market cap$476.1M
Dividend yield--
Data as of 02/26/2015

Growth & Valuation

Earnings growth (last year)-192.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-21.18%
P/E ratioNM
Price/Sales264.85
Price/Book4.54

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc+0.17+1.13%
EGRXEagle Pharmaceutical...+0.07+0.20%
PRQRProQR Therapeutics N...-0.21-1.05%
DVAXDynavax Technologies...-0.04-0.20%
Data as of 02/26/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$460.1K
Annual profit (last year)-$21.9M
Net profit margin-4,761.79%

Profile

Sector
Miscellaneous
Industry
Miscellaneous
President, Chief Executive Officer &
Director
Henry H. Ji
Chief Financial &
Accounting Officer
Douglas J. Langston
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account